BioLargo, Inc.
BLGO
Rank in Stocks
#26017
BioLargo, Inc. pioneers the invention, development, and commercialization of... BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
Share Price
$0.07
Last synced: 2026-11-11
Market Cap
$22.47M
Change (1 day)
0.00%
Change (1 year)
-58.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioLargo, Inc. (BLGO)
Category
Basic Materials
Operating Margin for BioLargo, Inc. (BLGO)
Operating Margin as of November 2026 TTM: -443.63%
According to BioLargo, Inc.'s latest financial reports, its current operating margin (TTM) is -443.63%. At the end of 2025 the company had an operating margin of -191.13%.
Operating Margin history for BioLargo, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -443.63% | 132.11% |
| 2025 | -191.13% | 684.61% |
| 2024 | -24.36% | -28.83% |
| 2023 | -34.23% | -60.66% |
| 2022 | -87.00% | -65.49% |
| 2021 | -252.11% | -17.66% |
| 2020 | -306.17% | -12.04% |
| 2019 | -348.09% | -25.95% |
| 2018 | -470.09% | -58.84% |
| 2017 | -1,141.98% | -34.95% |
| 2016 | -1,755.52% | -46.44% |
| 2015 | -3,277.49% | 7.80% |
| 2014 | -3,040.35% | 94.92% |
| 2013 | -1,559.82% | -78.33% |
| 2012 | -7,197.88% | 255.64% |
| 2011 | -2,023.91% | -24.43% |
| 2010 | -2,678.33% | -73.58% |
| 2009 | -10,138.78% | 0.00% |
| 2008 | 0.00% | -100.00% |
| 2007 | -4,730.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | -100.00% |
| 2001 | -905.25% | 251.08% |
| 2000 | -257.85% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 6.22% | -100.01% |
TW
|
|
| 25.36% | -100.06% |
JP
|
|
| 4.23% | -100.01% |
DE
|
|
| 7.07% | -100.02% |
SA
|
|
| 2.91% | -100.01% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BioLargo, Inc.'s operating margin
What is BioLargo, Inc.'s operating margin?
BioLargo, Inc.'s operating margin is -443.63%, as of Nov 2026.
What was BioLargo, Inc.'s operating margin in 2025?
In 2025, BioLargo, Inc.'s operating margin was -191.13%, compared with -24.36% in 2024.
How has BioLargo, Inc.'s operating margin changed since 2020?
From 2020 to 2025, BioLargo, Inc.'s operating margin was highest in 2024 (-24.36%) and lowest in 2020 (-306.17%).
How does BioLargo, Inc.'s operating margin compare with similar companies?
BioLargo, Inc.'s operating margin (-443.63%) is lower than that of all 5 similar companies listed above. The highest among them is Shin-Etsu Chemical Co., Ltd., with 25.36%.